Triple-negative breast cancers (TNBCs) are defined as those breast cancers that do not express the estrogen receptor (ER) or the progesterone receptor (PgR) and lack ERBB2 gene amplification [1]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.